EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

Abstract

BackgroundTremendous opportunities for health research have been unlocked by the recent expansion of big data and artificial intelligence. However, this is an emergent area where recommendations for optimal use and implementation are needed. The objective of these European League Against Rheumatism (EULAR) points to consider is to guide the collection, analysis and use of big data in rheumatic and musculoskeletal disorders (RMDs).MethodsA multidisciplinary task force of 14 international experts was assembled with expertise from a range of disciplines including computer science and artificial intelligence. Based on a literature review of the current status of big data in RMDs and in other fields of medicine, points to consider were formulated. Levels of evidence and strengths of recommendations were allocated and mean levels of agreement of the task force members were calculated.ResultsThree overarching principles and 10 points to consider were formulated. The overarching principles address ethical and general principles for dealing with big data in RMDs. The points to consider cover aspects of data sources and data collection, privacy by design, data platforms, data sharing and data analyses, in particular through artificial intelligence and machine learning. Furthermore, the points to consider state that big data is a moving field in need of adequate reporting of methods and benchmarking, careful data interpretation and implementation in clinical practice.ConclusionThese EULAR points to consider discuss essential issues and provide a framework for the use of big data in RMDs.

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations

“…The objective of this systematic literature review (SLR) was to obtain an overview of the existing literature on big data in RMDs, to inform a EULAR taskforce 17. In addition, to compare the current status of big data in RMDs with other medical fields, a ‘mirror’ review outside of RMDs was also performed.…”

On using machine learning algorithms to define clinically meaningful patient subgroups

“…Therefore, we applaud the ongoing discussion on how to reliably use 'big-data techniques' partly fueled by EULAR's point to consider for the use of big data (techniques). 3 To contribute to this discussion, we would like to challenge the statements made by Pinal-Fernandez and Mammen. 2…”

Greetings from the editor 2020

“…In this first issue of the new decade we provide the readers with a series of EULAR management recommendations, such as for Sjögren’s syndrome, large vessel vasculitis or vaccination12–14; EULAR recommendations for the diagnosis of gout, the role of the nurse and competences of health professionals in rheumatology15–17; EULAR points to consider for the use of big data18; and joint American College of Rheumatology-EULAR classification criteria for IgG4-related disease,19 which will appear in parallel with Arthritis & Rheumatology . In addition, you will find an updated viewpoint on unmet needs in rheumatology 11.…”